Ichor Holdings, Ltd. (ICHR) provides critical fluid delivery subsystems and precision components for semiconductor capital equipment. The company specializes in parts essential for manufacturing processes such as etch, deposition, and cleaning, supplying major original equipment manufacturers (OEMs) in the semiconductor space. Operating firmly in the technology sector—particularly semiconductor equipment and materials—ICHR delivers focused exposure to the cyclical semiconductor supply chain.
Unlike diversified ETFs, ICHR generates revenue mainly from gas, chemical delivery, and machined components for semi OEMs like AMAT and LRCX. This targeted reliance on WFE demand goes a long way in explaining its recent price action, as increases in chip production capacity directly enhance its order book and revenue prospects.
In the last 30 days, Ichor Holdings, Ltd. (ICHR) advanced +58%, climbing from about $42 to $66.54. The move was trend-based with moderate volatility, showing steady gains through April and peaking above $70 before a slight retreat. I also checked this using Tickeron’s AI Screener to compare it against peers in the sector.
Over the quarter, ICHR posted a +strong performance, rising from roughly $33 to current levels. Momentum built strongly from early-year lows during the sector recovery, with higher volume on up days and less sideways action.
The +58% rise in ICHR over the past 30 days reflects growing investor confidence in semiconductor equipment. Standout catalysts were analyst upgrades, including Stifel's Buy rating with a $55 target in March, alongside industry tailwinds from elevated WFE spending tied to AI chip demand.
Peers in semiconductors also advanced, boosting ICHR as its fluid delivery systems tie directly to rising capital equipment orders. Positive sentiment around preliminary Q4 2025 results and Q1 2026 guidance of at least $240 million in revenue added fuel. With institutional ownership above 100%, the rally held firm without notable selling pressure. The stock's beta of 1.67 underscores its link to sector moves, tying OEM capex expansion to ICHR's appreciation.
ICHR's +99% quarterly advance came from a semiconductor rebound, with global sales expected to reach record highs in 2026 on AI and data center growth. Broader trends like WFE recovery after the downturn and projections for $1.3 trillion in sector revenue by 2026 built sustained support.
Macro tailwinds from ongoing tech expansion overshadowed earlier inventory issues. Institutional buying, with BlackRock and Vanguard holding over 24% combined, bolstered the uptrend. ICHR outpaced the semiconductor equipment industry, which posted solid but less dramatic gains, thanks to demand for its specialized components from top OEMs.
One tool I find invaluable for dissecting stocks like ICHR is Tickeron’s AI Screener. This AI-powered platform lets me scan thousands of stocks and ETFs using filters for technical patterns, fundamentals, trends, volatility, and AI signals—such as industry, market cap, indicators, price patterns, and performance metrics. It uncovers trade ideas, breakouts, and opportunities far faster than manual reviews, helping refine my strategy. From what I see, it's a practical way to stay ahead in this fast-moving sector.
Keep an eye on the semiconductor outlook, especially WFE trends and AI infrastructure spending. Q1 2026 earnings on May 4 will shed light on revenue and margins. Monitor key OEM customers like AMAT and LRCX for demand cues. Broader factors include interest rates affecting tech capex and global chip supply dynamics. Risks center on cyclical slowdowns or order delays, while upsides may come from analyst updates or sector M&A.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
ICHR saw its Momentum Indicator move below the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In 76 of the 84 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for ICHR turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 39 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
ICHR moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ICHR crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
The 50-day moving average for ICHR moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ICHR entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for ICHR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +13.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICHR advanced for three days, in 253 of 328 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
ICHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.594) is normal, around the industry mean (6.211). P/E Ratio (-31.487) is within average values for comparable stocks, (81.436). Projected Growth (PEG Ratio) (0.251) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.761) is also within normal values, averaging (27.897).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. ICHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company whose subsidiary manufactures gas and chemical delivery systems for semiconductor process equipment
Industry ElectronicProductionEquipment